T&G Needs, BB Tower and Qualipharma were highlighted among the stocks in focus this morning. Reports covered an expanded shareholder benefit program, the acquisition of a large order and the performance of a transplant procedure.
Among the stocks in focus today, T&G Needs announced the introduction of a shareholder benefit program. Eligible shareholders will be those holding at least 700 shares as of the end of December each year, with benefit points awarded according to the number of shares held. The points will range from 5,000 to 90,000.
BB Tower won a large order centered on NAS storage products. The order is worth approximately ¥3.8 billion, with revenue recognition scheduled for the fiscal year ending December 2027.
Qualipharma announced that the first transplant procedure using the regenerative medicine product ReHeart had been performed.